CollPlant Biotechnologies Ltd (NASDAQ:CLGN) currently has a daily average trading volume of 30.91K but it saw 1218122 shares traded in last market. With a market cap of 38.93M USD, the company’s current market price of $3.40 came rising about 76.17 while comparing to the previous closing price of $1.93. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.00 and as low as $1.55.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Alliance Global Partners which initiated the stock as “Buy” in its note to investors issued on February 17, 2023, recommending a price target of $22.75 for it.
Over the week, CLGN’s stock price is moving 71.72% up while it is 53.85% when we observe its performance for the past one month. Year-to-date it is -5.56% down and over the past year, the stock is showing a downside performance of -45.07%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0. In next quarter, company is expected to be making quarterly sales of $9.74M as analysts are expecting the sales for current fiscal year at $37.47M and seeing the company making $63.63M in sales next year. Moreover, analysts are in estimates of $8.99M for current-quarter revenue.
Currently, CollPlant Biotechnologies Ltd’s total number of outstanding shares is 11.45M with 10.16% of that held by the insiders while 12.23% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -95.57% and return on equity (ROE) at -75.27%. It has a 340.00 of forward P/E ratio. Stock’s beta reads 0.88. Stock has a price to book (P/B) ratio of 3.14 while price to sale or P/S ratio amounts to 15.76. Its return on asset (ROA) is -58.38% on average.
